MEDIA COVERAGE
Can Covid-19 Vaccines Keep up with an Evolving Virus?
|
|
RTBF - Une société biotech française séduite par Liège
|
|
FierceBiotech - Osivax raises €8M for universal flu vaccine clinical trials
|
|
LABIOTECH.eu - French Startup's Universal Flu Vaccine Development Boosted by €8M Series A
|
|
EU-Startups - Lyon-based biotech startup Osivax raises €8 million in financing to develop novel, universal flu vaccines
|
|
FinSMEs - Osivax Raises €8M in Series A Funding
|
|
L'echo - Osivax s'installe à Liège pour y développer un vaccin universel contre la grippe
|
|
Ccimag - Osivax lève 8 millions d’euros et planifie l’ouverture de bureaux à Liège
|
|
Siliconcanals - French biotech startup Osivax secures €8M to develop universal vaccine against influenza
|
|
LABIOTECH.eu - The Top 10 Biotechs You’ll Find in Lyon
|
|
LeProgres - Le vaccin contre la grippe d’Osivax pourrait générer plus d’un milliard par an
|
|
LABIOTECH.eu - This Newly Founded French Biotech is All About Vaccines
|
|